OMX30 1 525 0,8%  OMXH25 3 711 0,5%  OMXC20 892 -0,1%  Dow 19 827 0,5%  Nas 5 063 0,2%  EUR 9,5181 -0,3%  USD 8,8684 -0,2%  Olja 55,5 2,4%  Guld 1 214 -0,5% 

Regeneron Pharmaceuticals Aktie

362,84USD -0,57USD -0,16%
<
Bolag
Terminer
Profil
>
<
Relaterade värdepapper
ETP:er
Obligationer
>

Fundamentala nyckeltal för Regeneron Pharmaceuticals

2015 2016e 2017e 2018e 2019e
Utdelning - - - - -
Direktavkastning (i %) - - - - -
PE-tal 44,97 33,76 26,88 21,77 18,39
Resultat/aktie 12,07 11,63 14,61 18,03 21,34

Nyheter om Regeneron Pharmaceuticals Inc.

Inga nyheter tillgängliga
ytterligare nyheter

Analyser om Regeneron Pharmaceuticals Inc.

ytterligare analyser

Regeneron Pharmaceuticals Peer Group

pagehit

Lägg till instrument

Vad tycker du?

Profil Regeneron Pharmaceuticals Inc.

till bolagsprofilen
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory condition and has product candidates in development in other areas of high unmet medical need, including hypercholesterolemia, oncology, rheumatoid arthritis, asthma and atopic dermatitis. Its products include EYLEA (aflibercept) injection, which is used for the treatment of neovascular age related macular degeneration; ARCALYST (rilonacept), which is used for the treatment of Cryopyrin-Associated Periodic Syndrome, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome; and PRALUENT (alirocumab) Injection for treatment of adults with heterozygous familial hypercholesterolemia or clinical atherosclerotic cardiovascular disease, who require additional lowering of LDL- C. Regeneron Pharmaceuticals was founded by Alferd G. Gilman, Leonard S. Schleifer and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.

Realtidskurs Regeneron Pharmaceuticals Inc.

Bid
362,70
USD
Ask
362,75
USD
Kurstid
21:59
Börsen BTT

Aktiekurs Regeneron Pharmaceuticals Inc. i USDPUSH CHART

Kurs 362,84 USD -0,57 -0,16 %
Kurstid 21:59:57
Datum 20.01.2017
Öppning 365,09
Gårdagen 362,84
Dagshögsta 369,57
Dagslägsta 362,02
52 v. högsta 484,45
52 v. lägsta 325,56
52 v. perf.
Volym (Antal) 43 363
Börsvärde (SEK) 335,63 Mrd
Börsen
Kurs för 362,84 USD från börsen BATS Trading motsvarar med aktuell växelkurssentspricht USD/SEK en kurs på 3 217,81 SEK.

Till aktien Regeneron Pharmaceuticals

Ticker
ISIN US75886F1075
Index BX Swiss - USA, NASDAQ Comp., S&P 500, NASDAQ 100

Regeneron Pharmaceuticals Nyckeltal

Börsvärde i SEK 335,63 Mrd
Free float % 74,71
Antal aktier mio. 103,56
Cashflow/aktie i lokal valuta 5,11
Bokvärde/aktie i lokal valuta 35,28
60 dagar vola 44,81
PBV 15,39

Regeneron Pharmaceuticals Historiska kurser

2017-01-19 363,41 25 330
2017-01-18 362,88 22 462
2017-01-17 363,30 33 588
2017-01-13 367,88 86 795
2017-01-12 364,45 31 426

Aktier i samma industri med bättre 1 års perf.

SIGA Technologies Inc. 559,5 %
Ariad Pharmaceuticals Inc. 353,9 %
Exelixis Inc. 311,1 %
Amylin Pharmaceuticals Inc. 264,9 %
Array BioPharma Inc. 259,2 %